Apple’s September unveiling will feature the Apple Watch Series 12, expected to keep the Series 11 design while nudging performance forward. Rumors point to a new 3 nm processor built on the same architecture that powered the S9 chip, promising faster cores and longer battery life for long‑term users and for premium customers.

While the watch keeps the familiar square‑edge case and interchangeable bands, Apple may introduce new color palettes. Software exclusives could arrive, but no major display upgrades are in the pipeline, keeping the focus on internal hardware rather than external aesthetics and as well as future updates for users who value performance over design.

Rumors also touch on health tracking, hinting at a full blood‑pressure monitor, expanded hypertension alerts, and blood‑glucose sensing, though Apple has yet to confirm any new medical sensors. A leaked code fragment suggested Touch ID could surface, yet the feature seems unlikely given battery and health‑feature trade‑offs for current watch owners.

At launch, the Series 12 will likely launch with the same price tier as its predecessor, targeting users who prefer longevity over trend. The incremental processor boost and potential health additions aim to keep the Apple Watch competitive against fitness‑centric rivals, solidifying its position as the industry’s premium smartwatch for tracking.